In Singapore, medical devices and drugs differ in registration through regulatory pathways and classification criteria. Medical devices are categorized by risk levels, requiring conformity assessments, while drugs undergo clinical trials and evaluations for safety and efficacy. The Health Sciences Authority (HSA) oversees both, but processes and documentation requirements vary significantly.
